Comparative risk of musculoskeletal adverse reactions among new users of dipeptidyl peptidase-4 inhibitors: A retrospective cohort study

  • Taehwan Park
  • , Maureen Bresnahan
  • , Scott K. Griggs
  • , Jiajing Chen
  • , Alex H. Cho
  • , Yolene Gousse
  • , Mark Feinglos

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number100022
JournalExploratory Research in Clinical and Social Pharmacy
Volume2
DOIs
StatePublished - Jun 2021

ASJC Scopus Subject Areas

  • Health, Toxicology and Mutagenesis
  • Pharmacology (medical)
  • Pharmacy

Keywords

  • Comparative risk
  • DPP4 inhibitors
  • Musculoskeletal adverse reactions
  • Pharmacoepidemiology

Cite this